Kim A. Caldwell

13.9k total citations · 2 hit papers
111 papers, 8.0k citations indexed

About

Kim A. Caldwell is a scholar working on Molecular Biology, Aging and Neurology. According to data from OpenAlex, Kim A. Caldwell has authored 111 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 48 papers in Aging and 43 papers in Neurology. Recurrent topics in Kim A. Caldwell's work include Genetics, Aging, and Longevity in Model Organisms (48 papers), Parkinson's Disease Mechanisms and Treatments (36 papers) and Alzheimer's disease research and treatments (14 papers). Kim A. Caldwell is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (48 papers), Parkinson's Disease Mechanisms and Treatments (36 papers) and Alzheimer's disease research and treatments (14 papers). Kim A. Caldwell collaborates with scholars based in United States, Germany and Australia. Kim A. Caldwell's co-authors include Guy A. Caldwell, Shusei Hamamichi, Susan Lindquist, Songsong Cao, Jean‐Christophe Rochet, Katherine E. Strathearn, Aaron D. Gitler, Antony A. Cooper, Kathryn J. Hill and Stephen DiNardo and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Kim A. Caldwell

108 papers receiving 7.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models

2006 1.1k citations Antony A. Cooper, Aaron D. Gitler et al. Science profile →
arrow encodes an LDL-receptor-related protein essential for Wingless signalling

2000 700 citations Kim A. Caldwell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim A. Caldwell United States	46	3.9k	2.8k	1.8k	1.8k	1.7k	111	8.0k
Guy A. Caldwell United States	47	3.7k 0.9×	3.5k 1.3×	2.5k 1.4×	2.0k 1.1×	2.0k 1.2×	117	8.7k
Jean‐Christophe Rochet United States	37	4.0k 1.0×	5.4k 1.9×	4.0k 2.3×	2.5k 1.4×	1.6k 1.0×	108	10.3k
Marta Martínez‐Vicente Spain	32	3.1k 0.8×	2.1k 0.7×	2.7k 1.5×	1.2k 0.7×	1.7k 1.0×	47	7.6k
Ruth S. Slack Canada	67	8.4k 2.2×	1.9k 0.7×	1.7k 1.0×	2.5k 1.4×	1.6k 0.9×	145	12.6k
Brian Spencer United States	43	3.0k 0.8×	2.8k 1.0×	2.5k 1.4×	1.7k 1.0×	1.0k 0.6×	77	7.8k
Dimitri Krainc United States	57	8.3k 2.1×	5.0k 1.8×	4.5k 2.6×	4.8k 2.7×	2.4k 1.4×	135	15.5k
Lichuan Yang United States	51	6.3k 1.6×	3.5k 1.3×	2.1k 1.2×	4.0k 2.3×	720 0.4×	79	10.7k
Céline Perier Spain	33	2.6k 0.7×	3.5k 1.2×	1.8k 1.0×	2.2k 1.2×	531 0.3×	41	6.7k
Han Seok Ko United States	33	4.0k 1.0×	4.2k 1.5×	2.0k 1.1×	2.2k 1.2×	1.0k 0.6×	58	8.5k
Matthew J. LaVoie United States	37	3.5k 0.9×	2.1k 0.8×	2.2k 1.3×	1.6k 0.9×	1.2k 0.7×	51	6.7k

Countries citing papers authored by Kim A. Caldwell

Since Specialization

Citations

This map shows the geographic impact of Kim A. Caldwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim A. Caldwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim A. Caldwell more than expected).

Fields of papers citing papers by Kim A. Caldwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim A. Caldwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim A. Caldwell. The network helps show where Kim A. Caldwell may publish in the future.

Co-authorship network of co-authors of Kim A. Caldwell

This figure shows the co-authorship network connecting the top 25 collaborators of Kim A. Caldwell. A scholar is included among the top collaborators of Kim A. Caldwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim A. Caldwell. Kim A. Caldwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caldwell, Kim A.. (2025). Liver Supportive Care – A Much Needed Service for Advanced Liver Disease. Journal of Pain and Symptom Management. 69(5). e727–e727.

Caldwell, Kim A., et al.. (2024). Exploring Misconceptions of Palliative Care Among Patients With Hepatocellular Carcinoma: A Pilot Study. American Journal of Hospice and Palliative Medicine®. 42(5). 467–476.

Park, Hana, et al.. (2023). Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease models. Proceedings of the National Academy of Sciences. 120(7). e2210712120–e2210712120. 8 indexed citations

Hamamichi, Shusei, et al.. (2022). Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans. PLoS Genetics. 18(8). e1010115–e1010115. 10 indexed citations

Fanning, Saranna, Jooyoung Jeong, Joon Yoon, et al.. (2022). Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy. npj Parkinson s Disease. 8(1). 74–74. 13 indexed citations

March, Zachary M., Hanna Kim, Xiaohui Yan, et al.. (2020). Therapeutic genetic variation revealed in diverse Hsp104 homologs. eLife. 9. 23 indexed citations

Hartman, Jessica H., Claudia P. González-Hunt, Samantha M. Hall, et al.. (2019). Genetic Defects in Mitochondrial Dynamics in Caenorhabditis elegans Impact Ultraviolet C Radiation- and 6-hydroxydopamine-Induced Neurodegeneration. International Journal of Molecular Sciences. 20(13). 3202–3202. 19 indexed citations

Griffin, Edward F., Kim A. Caldwell, & Guy A. Caldwell. (2017). Genetic and Pharmacological Discovery for Alzheimer’s Disease Using Caenorhabditis elegans. ACS Chemical Neuroscience. 8(12). 2596–2606. 48 indexed citations

Band, Rebecca, Christine Barrowclough, Kim A. Caldwell, Richard Emsley, & Alison Wearden. (2016). Activity patterns in response to symptoms in patients being treated for chronic fatigue syndrome: An experience sampling methodology study.. Health Psychology. 36(3). 264–269. 12 indexed citations

10.

Shephard, Freya, Christopher Gaffney, Nathaniel J. Szewczyk, et al.. (2013). Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases. Antioxidants and Redox Signaling. 20(2). 217–235. 48 indexed citations

11.

Tardiff, Daniel F., Nathan T. Jui, Vikram Khurana, et al.. (2013). Yeast Reveal a “Druggable” Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons. Science. 342(6161). 979–983. 200 indexed citations

12.

Jui, Nathan T., Stephen L. Buchwald, Susan Lindquist, et al.. (2013). Yeast Reveal a ‘Druggable’ Rsp5/Nedd4 Network That Ameliorates α-Synuclein Toxicity in Neurons. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations

13.

Bornhorst, Julia, Sudipta Chakraborty, Sören Meyer, et al.. (2013). The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Metallomics. 6(3). 476–490. 81 indexed citations

14.

Caldwell, Kim A., et al.. (2013). Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling. Neuroscience Letters. 541. 116–119. 17 indexed citations

15.

Liu, Zhaohui, Shusei Hamamichi, Byoung Dae Lee, et al.. (2011). Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. Human Molecular Genetics. 20(20). 3933–3942. 108 indexed citations

16.

Tardiff, Daniel F., et al.. (2011). Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms. Journal of Biological Chemistry. 287(6). 4107–4120. 61 indexed citations

17.

Nery, Flávia C., Jonathan E. Farley, Pan Chen, et al.. (2011). TorsinA participates in endoplasmic reticulum-associated degradation. Nature Communications. 2(1). 393–393. 87 indexed citations

18.

Churchill, Perry F., et al.. (2010). The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro. Cell Stress and Chaperones. 15(5). 605–617. 47 indexed citations

19.

Caldwell, Kim A., Tyler W. Hodges, Jue Chen, et al.. (2009). Investigating Bacterial Sources of Toxicity as an Environmental Contributor to Dopaminergic Neurodegeneration. PLoS ONE. 4(10). e7227–e7227. 44 indexed citations

20.

Cooper, Antony A., Aaron D. Gitler, Anil G. Cashikar, et al.. (2006). α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models. Science. 313(5785). 324–328. 1064 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact